4//SEC Filing
Shah Parag Suresh 4
Accession 0001104659-23-069911
CIK 0001600132other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:11 PM ET
Size
5.8 KB
Accession
0001104659-23-069911
Insider Transaction Report
Form 4
Shah Parag Suresh
VP Proj Mgmt & Distribution
Transactions
- Award
Stock Options (Right to Buy)
2023-06-07−50,000→ 50,000 totalExercise: $0.83Exp: 2033-06-07→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]This option was approved by the Compensation Committee of the Board of Directors of Bellerophon Therapeutics, Inc., on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the options were granted, which was approved by stockholders on June 7, 2023.
- [F2]This option vests in 16 quarterly installments commencing on the date hereof.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001673357
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:11 PM ET
- Size
- 5.8 KB